medigraphic.com
Instituto Nacional de Salud Pública

2021, Number 6

<< Back Next >>

salud publica mex 2021; 63 (6)

Epidemiology of hypertension in Mexican adults: diagnosis, control and trends. Ensanut 2020

Campos-Nonato I, Hernández-Barrera L, Oviedo-Solís C, Ramírez-Villalobos D, Hernández B, Barquera S

Language: Spanish
References: 31
Page: 692-704
PDF size: 355.77 Kb.


ABSTRACT

Objective. To describe the prevalence of hypertension in Mexican adults, the proportion with controlled blood pressure (BP), and the trend in the 2018-2020 period. Materials and methods. BP was measured in 9 844 adults who participated in the National Health and Nutrition Survey (Ensanut, in Spanish) 2020. They were considered to have hypertension or BP controlled when adults met the Eighth Joint National Committee (JNC-8) or American Heart Association (AHA) criteria. Results. The prevalence of hypertension was 49.4% (according to JNC-8), of which 70.0% were unaware of their diagnosis. When using AHA criteria, 30.2% of the adults had hypertension and 51.0% were unaware of your diagnosis. Among adults with a previous diagnosis of hypertension, 54.9% had controlled BP. Between the 2018-2020 period, no changes in prevalences were observed. Conclusions. At least a third of Mexican adults have hypertension and of them, at least half have not been diagnosed. The relevance of current hypertension diagnostic programs should be evaluated because underdiagnosis and poor control can lead to complications and death.


REFERENCES

  1. World Health Organization. A global brief on Hypertension. Silent killer, global public health crisis. Geneva: WHO, 2013. Disponible en: https://apps. who.int/iris/bitstream/handle/10665/79059/WHO_DCO_WHD_2013.2_ eng.pdf?sequence=1

  2. Oparil S, Acelajado MC, Bakris GL, Berlowitz DR, Cifkova R, Dominiczak AF, et al. Hypertension. Nat Rev Dis Primers. 2018;4:18014. https://doi. org/10.1038/nrdp.2018.14

  3. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: Update from the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982-3021. https://doi.org/10.1016/j.jacc.2020.11.010

  4. World Health Organization. Global status report on noncommunicable diseases 2010. Chapter 4. Burden: mortality, morbidity and risk factors. Geneva: WHO; 2011. Disponible en: https://apps.who.int/iris/bitstream/ handle/10665/44579/9789240686458_eng.pdf;jsessionid=73C0B8958E48E B28C1D77FB17DB4E5CE?sequence=1

  5. Campos-Nonato I, Hernandez-Barrera L, Flores-Coria A, Gomez- Alvarez E, Barquera S. Prevalence, diagnosis and control of hypertension in Mexican adults with vulnerable condition. Results of the Ensanut 100k. Salud Publica Mex. 2019;61(6):888-97. https://doi.org/10.21149/10574

  6. Whelton PK, Carey RM, Aronow WS, Casey DE, Jr., Collins KJ, Dennison- Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluaisquemia tion, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127-e248. https://doi.org/10.1016/j.jacc.2017.11.006

  7. Campos-Nonato I, Hernandez-Barrera L, Pedroza-Tobias A, Medina C, Barquera S. Hypertension in Mexican adults: prevalence, diagnosis and type of treatment. Ensanut MC 2016. Salud Publica Mex. 2018;60(3):233- 43. https://doi.org/10.21149/8813

  8. Romero-Martínez M, Barrientos T, Cuevas-Nasu L, Shamah-Levy T, Bautista- Arredondo S, Colchero A, et al. Metodología Encuesta Nacional de Salud y Nutrición 2020 sobre Covid-19. Salud Publica Mex. 2021;63:444- 51. https://doi.org/10.21149/12580

  9. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45(1):142-61. https://doi. org/10.1161/01.HYP.0000150859.47929.8e

  10. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-20. https://doi.org/10.1001/jama.2013.284427

  11. Lohman T, Roche M. Anthropometric standarization reference manual. Champlaign, IL: Human Kinetics, 1988.

  12. World Health Organization.. Physycal statuts: the use and interpretation of anthropometry. Geneva: WHO, 1995.

  13. Gotto AM, Ncep ATPIII. NCEP ATP III guidelines incorporate global risk assessment. Am J Manag Care. 2003;9(1):3-4.

  14. Konta T, Ichikawa K, Kawasaki R, Fujimoto S, Iseki K, Moriyama T, et al. Association between serum uric acid levels and mortality: a nationwide community-based cohort study. Sci Rep. 2020;10(1):6066. https://doi. org/10.1038/s41598-020-63134-0

  15. Coresh J, Wei GL, McQuillan G, Brancati FL, Levey AS, Jones C, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med. 2001;161(9):1207-16. https://doi.org/10.1001/archinte.161.9.1207

  16. American Diabetes A. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(supl 1):S15-S33. https://doi.org/10.2337/dc21-S002

  17. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223-37. https://doi.org/10.1038/s41581-019- 0244-2

  18. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441-50. https://doi.org/10.1161/CIRCULATIONAHA. 115.018912

  19. Sarki AM, Nduka CU, Stranges S, Kandala NB, Uthman OA. Prevalence of hypertension in low- and middle-income countries: a systematic review and meta-analysis. Medicine (Baltimore). 2015;94(50):e1959. https://doi. org/10.1097/MD.0000000000001959

  20. Sandberg K, Ji H. Sex differences in primary hypertension. Biol Sex Differ. 2012;3(1):7. https://doi.org/10.1186/2042-6410-3-7

  21. Cornoni-Huntley J, LaCroix AZ, Havlik RJ. Race and sex differentials in the impact of hypertension in the United States. The National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Intern Med. 1989;149(4):780-8.

  22. Reckelhoff JF. Gender differences in hypertension. Curr Opin Nephrol Hypertens. 2018;27(3):176-81. https://doi.org/10.1097/ MNH.0000000000000404

  23. Hall JE. The kidney, hypertension, and obesity. Hypertension. 2003;41(3):625-33. https://doi.org/10.1161/01.HYP.0000052314.95497.78

  24. Diaz ME. Hypertension and obesity. J Hum Hypertens. 2002;16 Suppl 1:S18-22. https://doi.org/10.1038/sj.jhh.1001335

  25. Viazzi F, Bonino B, Ratto E, Desideri G, Pontremoli R. Hyperuricemia, diabetes and hypertension. G Ital Nefrol. 2015;32(supl 62).

  26. Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions. Lancet. 2012;380(9841):601-10. https://doi.org/10.1016/ S0140-6736(12)60987-8

  27. Chahoud J, Mrad J, Semaan A, Asmar R. Prevalence of diabetes mellitus among patients with essential arterial hypertension. J Med Liban. 2015;63(2):74-80. https://doi.org/10.12816/0012554

  28. Mills KT, Obst KM, Shen W, Molina S, Zhang HJ, He H, et al. Comparative effectiveness of implementation strategies for blood pressure control in hypertensive patients: a systematic review and meta-analysis. Ann Intern Med. 2018;168(2):110-20. https://doi.org/10.7326/M17-1805

  29. Puddey IB, Beilin LJ. Alcohol is bad for blood pressure. Clin Exp Pharmacol Physiol. 2006;33(9):847-52. https://doi.org/10.1111/j.1440- 1681.2006.04452.x

  30. Collaboration NCDRF. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389(10064):37-55. https://doi. org/10.1016/S0140-6736(16)31919-5

  31. Schiffrin EL. Global Impact of the 2017 American College of Cardiology/ American Heart Association Hypertension Guidelines: A Perspective From Canada. Circulation. 2018;137(9):883-5. https://doi.org/10.1161/ CIRCULATIONAHA.117.032849




2020     |     www.medigraphic.com